Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/89129
Citations
Scopus Web of Science® Altmetric
?
?
Type: Conference paper
Title: 236 effect of cyclic adenosine monophosphate modulator regulators in association with bmp15 on bovine embryo development in vitro
Author: Machado, M.F.
Nogueira, M.F.
Gilchrist, R.B.
Sutton-McDowall, M.L.
Mottershead, D.G.
White, M.A.
Thompson, J.G.
Citation: Reproduction Fertility and Development, 2015, vol.27, iss.1, pp.207-208
Publisher: CSIRO
Issue Date: 2015
ISSN: 1031-3613
1448-5990
Conference Name: : Australia)
Statement of
Responsibility: 
M. F. Machado, M. F. G. Nogueira, R. B. Gilchrist, M. L. Sutton-McDowall, D. G. Mottershead, M. A. White and J. G. Thompson
Abstract: BMP15 is a promising peptide to improve oocyte competence; also, addition of cyclic adenosine monophosphate modulator (cAMP) regulators prevents spontaneous maturation in vitro and promotes embryo development. We aimed to assess embryo development after prematuration [pre-in vitro maturation (IVM)] with IBMX and Forskolin (FSK) and maturation in the presence or absence of a purified pro mature region of BMP15. Immature cumulus-oocyte complexes (COC) were cultured in vitroMat (IVF Vet Solutions, Adelaide, Australia) plus 4mgmL(-1) fatty acid free-BSA and rhFSH (0.1IUmL(-1)), then divided into the following treatment groups: 1) spontaneous IVM: 24h of IVM; 2) spontaneous IVM+BMP15: 24h of IVM in the presence of BMP15 (100ngmL(-1)); 3) Pre 2 h: pretreatment with IBMX (500µM; Sigma-Aldrich) and FSK (100µM; Sigma-Aldrich) for 2h following 24h maturation; and 4) Pre 2 h+BMP15: pretreatment with IBMX and FSK for 2h following 24h maturation in the presence of BMP15 (100ngmL(-1)). After maturation, oocytes were inseminated and zygotes were cultured for 5 days in VitroCleave (IVF Vet Solutions, Adelaide, Australia) and transferred into VitroBlast (IVF Vet Solutions, Adelaide, Australia) until blastocyst assessment (Days 7 and 8). Zona-intact embryos were retrieved to assess differential staining of trophectoderm and inner cell mass. Data were transformed into a logarithm and analysed by 1-way ANOVA and post hoc least significant difference using SigmaStat software (SPSS Inc., San Jose, CA, USA; P<0.05). There was no difference among groups on cleavage rates or blastocyst rates at Day 7; however, both Pre 2h treatments increase hatched blastocyst rates at Day 8 of embryo development (Table 1). Supplementation with BMP15 increased total blastocyst rates at Day 8, regardless of pretreatment with IBMX+FSK (Table 1). Our data demonstrate that embryos from oocytes matured in the presence of BMP15 or pretreated with IBMX+FSK increase trophectoderm and total cell numbers; however, no differences were observed for inner cell mass. We conclude that Pre 2h treatment or BMP15 increase embryo development; however, no effect of cAMP regulators in association with BMP15 on embryo development was observed.
Description: Proceedings of the Annual Conference of the International Embryo Transfer Society, Versailles, France, 10–13 January 2015
Rights: Copyright in the material available at this site is owned by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and third parties, and may only be used in the ways described in this legal notice: You may take temporary copies necessary to browse this site on-screen. Unless otherwise stated, you may download or print a single copy of CSIRO-copyright material for research or personal use. You must not change any of the material or remove any part of any copyright notice. Trademarks used on this site to describe firms and their products are trademarks of those firms or the registered proprietor of the trademark
DOI: 10.1071/rdv27n1ab236
Published version: http://dx.doi.org/10.1071/rdv27n1ab236
Appears in Collections:Aurora harvest 2
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.